November 2, 2006 |
Allergan Inc., maker of breast implants and Botox anti-wrinkle treatment, said quarterly profit fell 29% because of restructuring expenses and costs associated with its acquisition of Inamed Corp. The Irvine-based company, which also makes eye medications, said third-quarter net income was $106.4 million, or 70 cents a share, down from $150.5 million, or $1.12, a year earlier. Before exceptional items, the company earned 95 cents a share.
May 25, 1993
Allergan Inc., a provider of eye-care and other medical products, said it has agreed to conduct joint clinical trials of drugs with Summit Technology Inc. The companies will conduct joint clinical trials of certain drugs for use after a surgical procedure known as photorefractive keratectomy. The procedure involves the use of a laser to correct eye disorders such as nearsightedness, farsightedness and astigmatism.